EU Commission sends Statement of Objections to Lundbeck and others for preventing market entry of generic antidepressant medicine ("pay for delay")

Press release, here. See also the July, 16 "pay for delay" ruling delivered by the US Court of Appeals for the Third Circuit in re K-DUR ANTITRUST LITIGATION, here.